ICPerMed conference


Katherine Payne

The University of Manchester, UK


Professor Katherine Payne (ORCID: 0000-0002-3938-4350) is an academic health economist with 28-years applied and methodological research experience in the economic evaluation (using RCT and decision-analytic models) and valuation (using discrete choice experiments and contingent valuation) of health care interventions and specifically precision medicine. She developed an interest in genomics when working as the health economist for the North West Genetics Knowledge Park (2003 to 2007) and continues to collaborate closely with colleagues based in the Manchester Centre for Genomic Medicine. This research profile has supported her methodological interest of how to identify, measure and value the benefits of interventions that extend beyond the impact on health. She has over 150 peer-reviewed publications and had a key role in multi-disciplinary research programmes funded by Innovate UK, MRC, NIHR, Department of Health and Charities (Versus Arthritis and Cancer Research UK). She has been the lead economist on a number of large MRC-funded consortia looking at using targeted approaches (developing prescribing algorithms) for biologics and other medicines (for lupus, psoriasis, rheumatoid arthritis). She has a particular interest in the use of economic evidence to inform decision-making in practice and was a member of a NICE Technology Appraisal committee.